We are live on ! Find out more
RVMDW icon

Revolution Medicines Inc Warrant
RVMDW

22 hedge funds and large institutions have $1.89M invested in Revolution Medicines Inc Warrant in 2023 Q4 according to their latest regulatory filings, with 22 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

4.5% more ownership

Funds ownership: 0% → 4.5% (+4.5%)

Holders
22
Holders Change
+22
Holders Change %
–
% of All Funds
0.32%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
22
Increased
–
Reduced
–
Closed
–
Calls
$14.5M
Puts
–
Net Calls
+$14.5M
Net Calls Change
+$14.5M

Top Buyers

Rank Fund Capital Flow
1
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$602K
2
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$272K
3
Walleye Capital
Walleye Capital
New York
+$266K
4
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$223K
5
SCM
Soros Capital Management
New York
+$163K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
D.E. Shaw & Co
1
D.E. Shaw & Co
New York
$445K +$602K +1,347,439 New
BFM
2
Boothbay Fund Management
New York
$234K +$3.64K +8,144 New
T. Rowe Price Associates
3
T. Rowe Price Associates
Maryland
$201K +$272K +608,474 New
Walleye Capital
4
Walleye Capital
New York
$197K +$266K +595,986 New
Adage Capital Partners
5
Adage Capital Partners
Massachusetts
$165K +$223K +500,000 New
SCM
6
Soros Capital Management
New York
$120K +$163K +364,824 New
PA
7
Perceptive Advisors
New York
$82.5K +$112K +250,000 New
BL
8
Bleichroeder LP
New York
$66K +$89.3K +200,000 New
CAC
9
Cowen and Company
New York
$66K +$89.3K +199,900 New
SC
10
Sculptor Capital
New York
$61K +$79.6K +178,107 New
DKCM
11
Davidson Kempner Capital Management
New York
$49.5K +$67K +150,000 New
FCM
12
Farallon Capital Management
California
$39.6K +$53.6K +120,085 New
MF
13
Magnetar Financial
Illinois
$39.4K +$53.3K +119,289 New
CL
14
CSS LLC
Illinois
$35.3K +$5.31K +11,881 New
DIM
15
DLK Investment Management
California
$25.4K +$34.4K +77,000 New
WAM
16
Weiss Asset Management
Massachusetts
$24.3K +$32.9K +73,640 New
WAM
17
Wolverine Asset Management
Illinois
$23.2K +$31.4K +70,349 New
TD Asset Management
18
TD Asset Management
Ontario, Canada
$13.4K +$18.2K +40,636 New
TYCC
19
Texas Yale Capital Corp
Florida
$3.3K +$4.47K +10,000 New
UBS Group
20
UBS Group
Switzerland
$320 +$434 +971 New
TWC
21
TD Waterhouse Canada
Ontario, Canada
$133 +$200 +448 New
Osaic Holdings
22
Osaic Holdings
Arizona
$1 +$2 +4 New

RVMDW Hedge Fund Activity: Q4 2023 in Review

22 of the 6,860 institutional investors tracked by Wall St. Rank reported a position in Revolution Medicines Inc Warrant (RVMDW) for Q4 2023, worth a combined $1.89M.

Buyers outnumbered sellers: 22 funds opened new RVMDW positions and 0 closed out — a net gain of 22 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was D.E. Shaw & Co, opening a new position worth an estimated $602K.

  • 22 institutional investors held Revolution Medicines Inc Warrant (RVMDW) as of Q4 2023, up from 0 in Q3 2023.
  • Funds reported $1.89M of Revolution Medicines Inc Warrant stock for Q4 2023.
  • 22 funds opened new Revolution Medicines Inc Warrant positions in Q4 2023 and 0 closed out, a net change of +22 holders.
  • The largest Revolution Medicines Inc Warrant buyer in Q4 2023 was D.E. Shaw & Co, an estimated $602K added.

Based on aggregated 13F filings for Q4 2023.